Atopic dermatitis complicated by severe impetigo in a Syrian refugee infant

BMJ Case Reports
Peter Green, Elizabeth Munn

Abstract

We present the case of a 3-month-old infant with atopic dermatitis who developed severe impetigo. The child was born to Syrian refugees shortly after they arrived in Canada. The case demonstrates the rapid and nearly complete resolution of dramatic skin findings after a course of hydrocortisone ointment and oral antibiotics with adjuvant measures. For resettled refugees, access to family physicians and local language proficiency are common barriers that negatively impact their health and healthcare. We discuss some aspects of how the healthcare model in one Canadian city addresses these issues in the context of this case. The case also raises questions about the burden of dermatological conditions in refugees while in transit and in countries of resettlement. The few reports that exist suggest that some conditions may be relatively common and that the epidemiology warrants additional investigation.

References

Jun 18, 2002·Medical Care·Stanford Shoor, Kate R Lorig
Aug 26, 2009·Journal of Community Health·Meghan D MorrisKimberly C Brouwer
Jun 10, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kevin PottieUNKNOWN coauthors of the Canadian Collaboration for Immigrant and Refugee Health
Jan 10, 2012·Current Opinion in Pediatrics·Keith W Morley, James G Dinulos
Jul 19, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·J RingUNKNOWN Global Allergy and Asthma European Network (GA2LEN)
Jul 23, 2013·Lancet·Marwan M Refaat, Kamel Mohanna
Sep 3, 2014·The Australasian Journal of Dermatology·Hui Mei Cheng, Sujith Prasad Kumarasinghe
Mar 4, 2015·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·I-Hao ChengPeter Schattner
Jun 20, 2015·The Lancet Infectious Diseases·Lucia RomaniJohn M Kaldor
Sep 18, 2015·Lancet·Stephan Weidinger, Natalija Novak
Nov 28, 2015·Primary Care·Fadi IbrahimGeorge G A Pujalte
Jan 13, 2016·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kevin PottieLaurence J Kirmayer
Mar 19, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Frank P MockenhauptPatricia Schlagenhauf
Jun 28, 2016·PLoS Neglected Tropical Diseases·Daniel S MasonDaniel Engelman
Nov 24, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Cord SunderkötterHenning Hamm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.